Wells Fargo raised the firm’s price target on Bath & Body Works to $42 from $40 and keeps an Equal Weight rating on the shares. The high bar was not hurdled as Bath & Body’s margin upside and recovery was offset by a weaker revenue outlook for both Q1 and 2024, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BBWI:
- BBWI Earnings: Bath & Body Works Plunges on Dismal Outlook
- Bath & Body Works Unveils Q4 and Annual Financials with 2024 Guidance
- Bath & Body Works Reports Fourth Quarter and Full-Year 2023 Results and Provides 2024 Outlook
- Bath & Body Works sees Q1 EPS 28c-33c, consensus 39c
- Bath & Body Works sees FY24 EPS $3.00-$3.35, consensus $3.34
